Triova Pharmaceuticals is recalling 210 grams of Estriol USP Micronized 5 G, a prescription drug. The recall was initiated because the product failed testing for organic impurities, meaning it is "out of specification" and may contain degradation products or impurities beyond safe levels. This recall affects one specific lot of the medication with an expiration date of December 2020.
The presence of organic impurities or degradation products in a prescription medication can reduce the drug's effectiveness or cause unexpected side effects. While no specific injuries have been reported, the medication no longer meets the safety and quality standards required for pharmaceutical use.
Healthcare provider consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.